Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9KUQ

Crystal structure of a C45 isoprenyl diphosphate synthase, Rv0562 from Mycobacterium tuberculosis

Summary for 9KUQ
Entry DOI10.2210/pdb9kuq/pdb
DescriptorNonaprenyl diphosphate synthase (2 entities in total)
Functional Keywordsisoprenyl diphosphate synthases, terpenoids, transferase
Biological sourceMycobacterium tuberculosis
Total number of polymer chains1
Total formula weight35598.25
Authors
Wang, Q.,Yang, Y.,Chen, C.-C.,Guo, R.-T. (deposition date: 2024-12-04, release date: 2025-07-09)
Primary citationWang, Q.,Yang, Y.,He, B.,Huang, J.W.,Kuo, C.J.,Chen, C.C.,Guo, R.T.
Structural insight of a bi-functional isoprenyl diphosphate synthase Rv0562 from Mycobacterium tuberculosis.
Int.J.Biol.Macromol., :145171-145171, 2025
Cited by
PubMed Abstract: Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis. Mtb uses MK-9(II-H), which consists of an isoprenyl side chain containing nine isoprene units, with one being hydrogenated in the β-position, as an essential element in the electron transport system. Rv0562 that can operate geranylgeranyl diphosphate synthase (GGPPs) activity catalyzes the synthesis of MK-9(II-H) by condensing one molecule of DMAPP with eight molecules of isopentenyl diphosphate (IPP) to form a C long-chain isoprenoid product. In this study, the structures of Rv0562 were determined in the apo-form at a resolution of 2.54 Å and in complex with IPP and Mg at a resolution of 1.89 Å, revealing detailed interactions between the enzyme and substrates. Moreover, the crystal structure of the Rv0562-DM variant was determined at 2.27 Å resolution in complex with polyethylene glycol (PEG), which occupies the substrate binding tunnel, mimicking the long-chain product. The chain length determination mechanism of Rv0562 is also probed through mutagenesis experiments. The obtained structures help us understand how Rv0562 catalyzes isoprenyl chain elongation, showing implications in developing new anti-Mtb treatments.
PubMed: 40513738
DOI: 10.1016/j.ijbiomac.2025.145171
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

238582

PDB entries from 2025-07-09

PDB statisticsPDBj update infoContact PDBjnumon